Pyrimisulfan is a novel paddy herbicide that was discovered and developed by Kumiai Chemical Industry Co., Ltd.; Ihara Chemical Industry Co., Ltd.; and K-I Chemical Research Institute Co., Ltd. It was registered in Japan in 2010 and launched the first one-shot herbicide containing only one active ingredient (a.i.) developed with our original formulation technology. The compound is sulfonanilide, having a pyrimidinyl-containing group at the 2′-position and an acetolactate synthase (ALS) inhibitor. Pyrimisulfan shows broad-spectrum weed control against annual grass, sedge, broadleaf, and sulfonylurea-resistant weeds without causing phytotoxic injury to rice. At doses of 50-75 g a.i./ha, pyrimisulfan has a wide application window and exhibits long residual activity against these weeds. Pyrimisulfan has favorable toxicological, ecotoxicological, and environmental profiles.
We tried to develop a novel easy-to-use labor-saving formulation. And we have developed the "MAMETSUBU" formulation for paddy fields. This formulation has 3 to 8 mm diameters and disperses on the surface of water. This is a highly labor-saving formulation that can be applied from the levees by various methods without the necessity of stepping into the paddy fields. The conditions that disturb diffusion of an active ingredient in the "MAMETSUBU" formulation often changes. Therefore, spreading property of an active ingredient in the formulations was evaluated not only in small experimental fields but also in the actual paddy fields. In all of the experiments, the spreading property of the active ingredient was found sufficient enough for the formulations to be practically used. The conditions of paddy fields are usually not the same, but the "MAMETSUBU" formulation is a new formulation that can be reasonably applied.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.